FLUDAN CODEÍNA 10 mg/ 5 ml SOLUCIÓN ORAL Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

fludan codeína 10 mg/ 5 ml solución oral

faes farma s.a. - codeina fosfato - soluciÓn oral - 10 mg/5 ml - codeina fosfato 2 mg - codeína

PARACETAMOL/CODEINA KERN PHARMA 500 mg/30 mg COMPRIMIDOS EFG Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

paracetamol/codeina kern pharma 500 mg/30 mg comprimidos efg

kern pharma s.l. - paracetamol; codeina - comprimido - 500 mg/30 mg - paracetamol 500 mg; codeina 30 mg - codeina y paracetamol

PARACETAMOL/CODEINA FARMALIDER 500 MG/30 MG COMPRIMIDOS EFG Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

paracetamol/codeina farmalider 500 mg/30 mg comprimidos efg

farmalider s.a. - paracetamol; codeina fosfato hemihidrato - comprimido - 500 mg/30 mg - paracetamol 500 mg; codeina fosfato hemihidrato 30 mg - codeina y paracetamol

PARACETAMOL/CODEINA PENSA 500 MG/30 MG COMPRIMIDOS EFG Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

paracetamol/codeina pensa 500 mg/30 mg comprimidos efg

towa pharmaceutical s.a. - paracetamol; codeina fosfato hemihidrato - comprimido - 500 mg/30 mg - paracetamol 500 mg; codeina fosfato hemihidrato 30 mg - codeina y paracetamol

Codeine Phosphate Tablets (Noumed) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

codeine phosphate tablets (noumed)

noumed pharmaceuticals limited - codeine phosphate hemihydrate 15mg;  ;  ;  ;   - tablet - 15 mg - active: codeine phosphate hemihydrate 15mg         excipient: lactose monohydrate magnesium stearate maize starch - codeine phosphate is indicated for: the relief of mild to moderate pain (including pain associated with terminal illness, post-operative pain and headache), the relief of symptoms of diarrhoea (except diarrhoea caused by poisoning),

Codeine Phosphate Tablets (Noumed) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

codeine phosphate tablets (noumed)

noumed pharmaceuticals limited - codeine phosphate hemihydrate 30mg;  ;  ;  ;   - tablet - 30 mg - active: codeine phosphate hemihydrate 30mg         excipient: acacia lactose monohydrate magnesium stearate maize starch purified talc - codeine phosphate is indicated for: the relief of mild to moderate pain (including pain associated with terminal illness, post-operative pain and headache), the relief of symptoms of diarrhoea (except diarrhoea caused by poisoning),

Codeine Phosphate Tablets (Noumed) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

codeine phosphate tablets (noumed)

noumed pharmaceuticals limited - codeine phosphate hemihydrate 60mg;  ;  ;  ;   - tablet - 60 mg - active: codeine phosphate hemihydrate 60mg         excipient: lactose monohydrate magnesium stearate maize starch - codeine phosphate is indicated for: the relief of mild to moderate pain (including pain associated with terminal illness, post-operative pain and headache), the relief of symptoms of diarrhoea (except diarrhoea caused by poisoning),

PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE solution USA - engelsk - NLM (National Library of Medicine)

promethazine hydrochloride and codeine phosphate solution

akorn - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - codeine phosphate 10 mg in 5 ml - promethazine hcl and codeine phosphate oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use: promethazine hcl and codeine phosphate oral solution is contraindicated for: promethazine hcl and codeine phosphate oral solution is also contraindicated in patients with: risk summary promethazine hcl and codeine phosphate oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.19), clinical considerations ]. there are no available data with promethazine hcl and codeine phosphate oral solution use in pregnant women to inform a drug-associated risk for adverse developmental outcomes. published studies with codeine have reported inconsistent findings and have important methodological limitations (see

Codeine Linctus BP Malta - engelsk - Medicines Authority

codeine linctus bp

lcm limited linthwaite laboratories, huddersfield, hd7 5qh, united kingdom - codeine phosphate - oral solution - codeine phosphate 15 mg/5ml - cough and cold preparations